Comerica Bank Arrowhead Pharmaceuticals, Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Comerica Bank holds 38,180 shares of ARWR stock, worth $723,892. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,180

Previous 44,272 13.76%

Holding current value

$723,892

Previous $1.15 Million 35.74%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.36 - $29.54 $117,941 - $179,957	-6,092 Reduced 13.76%	38,180 $739,000
Q2 2024 Aug 15, 2024	SELL	$21.87 - $28.24 $88,354 - $114,089	-4,040 Reduced 8.36%	44,272 $1.15 Million
Q1 2024 May 15, 2024	BUY	$27.21 - $39.48 $132,104 - $191,675	4,855 Added 11.17%	48,312 $1.38 Million
Q4 2023 Feb 14, 2024	SELL	$21.2 - $31.03 $1,081 - $1,582	-51 Reduced 0.12%	43,457 $1.33 Million
Q3 2023 Nov 21, 2023	BUY	$26.2 - $36.08 $1.14 Million - $1.57 Million	43,508 New	43,508 $1.17 Million
Q4 2022 Jan 26, 2023	SELL	$28.0 - $40.56 $23,660 - $34,273	-845 Reduced 1.78%	46,658 $0
Q3 2022 Oct 28, 2022	SELL	$29.63 - $48.31 $22,370 - $36,474	-755 Reduced 1.56%	47,503 $1.49 Million
Q2 2022 Aug 02, 2022	SELL	$27.79 - $50.61 $2,084 - $3,795	-75 Reduced 0.16%	48,258 $2.06 Million
Q1 2022 Apr 27, 2022	BUY	$39.62 - $69.97 $90,373 - $159,601	2,281 Added 4.95%	48,333 $2.22 Million
Q4 2021 Feb 18, 2022	SELL	$58.09 - $82.51 $71,450 - $101,487	-1,230 Reduced 2.6%	46,052 $3.05 Million
Q3 2021 Nov 22, 2021	SELL	$58.38 - $84.96 $553,150 - $804,995	-9,475 Reduced 16.69%	47,282 $2.95 Million
Q2 2021 Aug 26, 2021	SELL	$62.15 - $90.32 $54,878 - $79,752	-883 Reduced 1.53%	56,757 $4.7 Million
Q1 2021 Apr 28, 2021	SELL	$61.35 - $90.47 $152,822 - $225,360	-2,491 Reduced 4.14%	57,640 $3.82 Million
Q4 2020 Jan 28, 2021	SELL	$43.82 - $85.37 $60,559 - $117,981	-1,382 Reduced 2.25%	60,131 $4.61 Million
Q3 2020 Oct 30, 2020	SELL	$33.21 - $51.27 $15,276 - $23,584	-460 Reduced 0.74%	61,513 $2.65 Million
Q2 2020 Jul 31, 2020	BUY	$26.12 - $43.27 $118,819 - $196,835	4,549 Added 7.92%	61,973 $2.68 Million
Q1 2020 May 01, 2020	BUY	$20.56 - $63.12 $246 - $757	12 Added 0.02%	57,424 $1.65 Million
Q4 2019 Feb 07, 2020	SELL	$28.14 - $73.01 $895,471 - $2.32 Million	-31,822 Reduced 35.66%	57,412 $3.64 Million
Q3 2019 Oct 31, 2019	BUY	$26.26 - $34.86 $16,465 - $21,857	627 Added 0.71%	89,234 $2.51 Million
Q2 2019 Aug 02, 2019	BUY	$17.43 - $28.82 $1.54 Million - $2.55 Million	88,607 New	88,607 $0

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account